Mesenchymal Stem Cells Modulate Albumin-Induced Renal Tubular Inflammation and Fibrosis
Hao Wu(Washington University in St. Louis), Sydney Tang(Chinese University of Hong Kong)
Cited by 80
Related Papers
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
|The Lancet|2023|264
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
|The Lancet|2023|214
Trans-ethnic kidney function association study reveals putative causal genes and effects on kidney-specific disease aetiologies
|Nature Communications|2018|160
Bradykinin and high glucose promote renal tubular inflammation
|Nephrology Dialysis Transplantation|2009|75